|
Volumn 13, Issue 2, 2001, Pages
|
Helicobacter pylori eradication in functional dyspepsia: New evidence for symptomatic benefit
|
Author keywords
Eradication; Functional dyspepsia; Helicobacter pylori; Symptom improvement
|
Indexed keywords
LANSOPRAZOLE;
2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE;
DRUG DERIVATIVE;
OMEPRAZOLE;
PROTON PUMP;
ANTIBIOTIC AGENT;
CHRONIC GASTRITIS;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DYSPEPSIA;
ERADICATION THERAPY;
GASTRODUODENAL ULCER;
HELICOBACTER PYLORI;
HUMAN;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
SYMPTOM;
ARTICLE;
CHRONIC DISEASE;
DRUG ANTAGONISM;
GASTRITIS;
HELICOBACTER INFECTION;
MICROBIOLOGY;
TREATMENT OUTCOME;
ANTIBIOTIC THERAPY;
GRAM NEGATIVE INFECTION;
PRACTICE GUIDELINE;
RISK BENEFIT ANALYSIS;
2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES;
CHRONIC DISEASE;
DYSPEPSIA;
GASTRITIS;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMANS;
OMEPRAZOLE;
PROTON PUMPS;
TREATMENT OUTCOME;
|
EID: 0034812798
PISSN: 09699163
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (19)
|
References (18)
|